{
    "Trade/Device Name(s)": [
        "TPUC3 Total Protein Urine/CSF Gen.3",
        "Total Protein Urine/CSF Gen.3"
    ],
    "Submitter Information": "Roche Diagnostics Operations",
    "510(k) Number": "K141925",
    "Predicate Device Reference 510(k) Number(s)": [
        "K071239"
    ],
    "Regulatory Class": "Class I exempt, meets limitations of exemptions per 862.9 (c)(1)(4)",
    "Product Code(s)": [
        "JIQ"
    ],
    "Summary Letter Date": "November 7, 2014",
    "Summary Letter Received Date": "November 10, 2014",
    "Submission Date": "July 15, 2014",
    "Regulation Number(s)": [
        "21 CFR 862.1645"
    ],
    "Regulation Name(s)": [
        "Urinary protein or albumin (nonquantitative) test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Total Protein"
    ],
    "Specimen Type(s)": [
        "Urine",
        "Cerebrospinal fluid"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "COBAS Integra 400 plus analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Turbidimetric method"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for TPUC3 Total Protein Urine/CSF Gen.3 turbidimetric assay for quantitative determination of total protein in urine and CSF using COBAS Integra 400 plus.",
    "Indications for Use Summary": "Quantitative determination of total protein in urine and cerebrospinal fluid to aid in diagnosis and treatment of renal, heart, thyroid diseases, meningitis, brain tumors, and central nervous system infections.",
    "fda_folder": "Clinical Chemistry"
}